FITC Anti-Human CD95 (DX2)
CD95 Monoclonal Antibody for FC
Host / Isotype
Mouse / IgG1, kappa
Reactivity
Human
Applications
FC
Conjugate
FITC Fluorescent Dye
CloneNo.
DX2
Cat no : FITC-65071
Synonyms
Validation Data Gallery
Tested Applications
Positive FC detected in | human peripheral blood lymphocytes |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 10 µl per 10^6 cells in a 100 µl suspension or 10 µl per 100 µl of whole blood. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
FITC-65071 targets CD95 in FC applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Host / Isotype | Mouse / IgG1, kappa |
Class | Monoclonal |
Type | Antibody |
Immunogen | Human CD95 transfected L cells |
Full Name | Fas (TNF receptor superfamily, member 6) |
Calculated Molecular Weight | 35-38 kDa |
GenBank Accession Number | BC012479 |
Gene Symbol | FAS |
Gene ID (NCBI) | 355 |
RRID | AB_2920494 |
Conjugate | FITC Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 498 nm / 526 nm |
Form | Liquid |
Purification Method | Affinity purification |
Storage Buffer | PBS with 0.1% sodium azide. |
Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Background Information
Fas (CD95/APO-1) is a transmembrane glycoprotein belonging to the tumor necrosis factor (TNF) receptor superfamily. It can mediate apoptosis by ligation with an agonistic anti-Fas antibody or Fas ligand. Stimulation of Fas results in the aggregation of its intracellular death domains, leading to the formation of the death-inducing signaling complex (DISC). FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both.
Protocols
Product Specific Protocols | |
---|---|
FC protocol for FITC CD95 antibody FITC-65071 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |